These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 18584942)

  • 1. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    Malats N; Real FX
    Eur Urol; 2009 Mar; 55(3):658. PubMed ID: 18584942
    [No Abstract]   [Full Text] [Related]  

  • 2. Editorial comment on: FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    Burger M
    Eur Urol; 2009 Mar; 55(3):657. PubMed ID: 18584941
    [No Abstract]   [Full Text] [Related]  

  • 3. FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
    van Oers JM; Zwarthoff EC; Rehman I; Azzouzi AR; Cussenot O; Meuth M; Hamdy FC; Catto JW
    Eur Urol; 2009 Mar; 55(3):650-7. PubMed ID: 18584939
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Editorial comment on: Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
    Montironi R; Lopez-Beltran A; Cheng L
    Eur Urol; 2008 Oct; 54(4):843-4. PubMed ID: 18166261
    [No Abstract]   [Full Text] [Related]  

  • 5. Editorial comment.
    Weiss RE
    Urology; 2010 Feb; 75(2):333. PubMed ID: 20152483
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial comment.
    Shayegan B
    Urology; 2010 Feb; 75(2):332-3. PubMed ID: 20152482
    [No Abstract]   [Full Text] [Related]  

  • 7. The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients.
    Yuan X; Liu C; Wang K; Liu L; Liu T; Ge N; Kong F; Yang L; Björkholm M; Fan Y; Zhao S; Xu D
    Oncotarget; 2016 May; 7(18):25826-35. PubMed ID: 27029078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma.
    Akdogan B; Dogan HS; Eskicorapci SY; Sahin A; Erkan I; Ozen H
    J Urol; 2006 Jul; 176(1):48-52. PubMed ID: 16753365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upper urinary tract carcinoma in Lynch syndrome cases.
    Crockett DG; Wagner DG; Holmäng S; Johansson SL; Lynch HT
    J Urol; 2011 May; 185(5):1627-30. PubMed ID: 21419447
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Genetic features of urothelial carcinoma of the bladder and the upper urinary tract].
    Cussenot O; Davin JL
    Prog Urol; 2003 Nov; 13(5 Suppl 2):1233. PubMed ID: 15816391
    [No Abstract]   [Full Text] [Related]  

  • 11. CDKN2A homozygous deletion is associated with muscle invasion in FGFR3-mutated urothelial bladder carcinoma.
    Rebouissou S; Hérault A; Letouzé E; Neuzillet Y; Laplanche A; Ofualuka K; Maillé P; Leroy K; Riou A; Lepage ML; Vordos D; de la Taille A; Denoux Y; Sibony M; Guyon F; Lebret T; Benhamou S; Allory Y; Radvanyi F
    J Pathol; 2012 Jul; 227(3):315-24. PubMed ID: 22422578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upper tract transitional cell carcinoma: finding a way forward.
    Clark PE
    Cancer; 2007 Oct; 110(8):1648-9. PubMed ID: 17722110
    [No Abstract]   [Full Text] [Related]  

  • 13. [Urothelial cancer of the upper urinary tract].
    Jurincic-Winkler C; Horlbeck R; Gasser A; Glenewinkel J; Klippel KF
    Urologe A; 1993 Jul; 32(4):295-9. PubMed ID: 8372411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study.
    Burger M; van der Aa MN; van Oers JM; Brinkmann A; van der Kwast TH; Steyerberg EC; Stoehr R; Kirkels WJ; Denzinger S; Wild PJ; Wieland WF; Hofstaedter F; Hartmann A; Zwarthoff EC
    Eur Urol; 2008 Oct; 54(4):835-43. PubMed ID: 18166262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer.
    Dodurga Y; Tataroglu C; Kesen Z; Satiroglu-Tufan NL
    Genet Mol Res; 2011 Jan; 10(1):86-95. PubMed ID: 21264819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract.
    Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H
    Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract.
    Kang CH; Yu TJ; Hsieh HH; Yang JW; Shu K; Huang CC; Chiang PH; Shiue YL
    Cancer; 2003 Oct; 98(8):1620-6. PubMed ID: 14534877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superficial transitional cell carcinoma of the ureteral orifice: higher risk of developing subsequent upper urinary tract tumors.
    Chou EC; Lin AT; Chen KK; Chang LS
    Int J Urol; 2006 Jun; 13(6):682-5. PubMed ID: 16834642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic criteria in patients with renal pelvic and ureteral cancers--clinical value of volume weighted mean nuclear volume].
    Aoyama T; Fujikawa K; Sasaki M
    Hinyokika Kiyo; 1996 Nov; 42(11):841-5. PubMed ID: 8973933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.